Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poon

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Clinical Colorectal Cancer|January 25, 2005
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group studyStacy D'Andre, Daniel J Sargent, Stephen S Cha, et al.
Gynecologic Oncology|August 1, 1994
Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinomaH J Long, R A Nelimark, J Q Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment GroupS A Cullinan, C G Moertel, H S Wieand, et al.
The Journal of Urology|November 18, 2011
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomyBehfar Ehdaie, Alexandra Maschino, Shahrokh F Shariat, et al.
Genes and Immunity|February 18, 2011
Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseasesS L Musone, K E Taylor, J Nititham, et al.
Applied and Environmental Microbiology|December 3, 1998
Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754J K McCormick, A Poon, M Sailer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trialsC L Loprinzi, E M Messing, J R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancerM A Poon, M J O'Connell, H S Wieand, et al.
BJU International|February 21, 2014
Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancerJonathan L Silberstein, Stephen A Poon, Daniel D Sjoberg, et al.
Transfusion Medicine (Oxford, England)|May 27, 2017
Blood donors' attitudes towards voluntary non-remunerated donation in Trinidad and TobagoK S Charles, A Poon King, A Ramai, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Clinical Colorectal Cancer|January 25, 2005
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group studyStacy D'Andre, Daniel J Sargent, Stephen S Cha, et al.
Gynecologic Oncology|August 1, 1994
Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinomaH J Long, R A Nelimark, J Q Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment GroupS A Cullinan, C G Moertel, H S Wieand, et al.
The Journal of Urology|November 18, 2011
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomyBehfar Ehdaie, Alexandra Maschino, Shahrokh F Shariat, et al.
Genes and Immunity|February 18, 2011
Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseasesS L Musone, K E Taylor, J Nititham, et al.
Applied and Environmental Microbiology|December 3, 1998
Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754J K McCormick, A Poon, M Sailer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trialsC L Loprinzi, E M Messing, J R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancerM A Poon, M J O'Connell, H S Wieand, et al.
BJU International|February 21, 2014
Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancerJonathan L Silberstein, Stephen A Poon, Daniel D Sjoberg, et al.
Transfusion Medicine (Oxford, England)|May 27, 2017
Blood donors' attitudes towards voluntary non-remunerated donation in Trinidad and TobagoK S Charles, A Poon King, A Ramai, et al.
Pageof 12